New Standard: Blinatumomab + Chemo in Childhood Acute Lymphoblastic Leukemia | Rachel Rau, MD|#ASH24
Dr. Rachel Rau from Seattle Children's Hospital discusses the groundbreaking results of a study using blinatumomab with chemotherapy for children with B-cell acute lymphoblastic leukemia that has since changed the way newly diagnosed pediatric patients are treated across the United States. Link to ASH playlist: https://healthtree.org/blood-cancer/u... ASH Abstract: Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731 #ASH24 #leusm Follow HealthTree: https://linktr.ee/HealthTreeUniversity
▶︎
Rachel E. Rau, MD & Sumit Gupta, MD, PhD: Blinatumomab in Pediatric B-ALL
▶︎
Childhood leukemia: Mayo Clinic Radio
▶︎
Odronextamab as First-Line Therapy in Follicular Lymphoma | Ruemu Birhiray, MD | #ASH24
▶︎
Emily Whitehead First Child Treated in Trial of T Cell Therapy for Acute Lymphoblastic Leukemia
▶︎
Chronic Cancer Tests: Chronic Lymphocytic Leukemia | The Patient Story
▶︎
The French Do Not Care About Work
▶︎
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
▶︎
Woman Allergic to Everything Except 2 Foods
▶︎
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia- R. Raja
▶︎
Factors Influencing Enrollment in Hematologic Cancer Trials (2008-2023) | Rupayan Kundu, MD | #ASH24
▶︎
How Long Can I Live with CLL? (Chronic Lymphocytic Leukemia) | The Patient Story
▶︎
Blinatumomab and ponatinib for newly diagnosed Ph+ ALL: updated results and predictors of relapse
▶︎
What Really Matters in Life? A Cancer Surgeon's Warning After 15,000 Patients
▶︎
Your Baby's Metabolism is Being Decided Right Now | Jessie Inchauspé
▶︎
A trial investigating the addition of blinatumomab to consolidation chemotherapy in Ph- ALL
▶︎
What I Wish Everyone Knew About Cancer
▶︎
Barriers to Stem Cell Transplant in #AML: NC Cohort Insights | Michele Sainvil, MD | #ASH24
▶︎
BTK Degrader Study Shows Promise for a New Class of CLL Therapies | Alexey Danilov MD PhD | #ASH2024
▶︎
Blinatumomab in B-Cell Acute Lymphoblastic Leukemia | NEJM
▶︎